87 related articles for article (PubMed ID: 6302412)
1. [Studies on the combined effect of 6/N,N-hexyleneformamidine/-penicillanic acid (Preparation HX) and selected beta-lactam antibiotics on Escherichia coli and Salmonella. II. Studies in vivo].
Zaremba M; Zukowska-Nytko K; Borowski J
Med Dosw Mikrobiol; 1982; 34(3-4):149-58. PubMed ID: 6302412
[No Abstract] [Full Text] [Related]
2. [Combined effect of 6/N,N-1',6'-hexyleneformamidine-penicillanic acid (preparation HX) and selected beta-lactam antibiotics on E. coli and Salmonella. I. Studies in vitro].
Zaremba M; Zukowska-Nytko K; Borowski J
Med Dosw Mikrobiol; 1982; 34(1-2):27-36. PubMed ID: 6292594
[No Abstract] [Full Text] [Related]
3. Systemic infections treated with amdinocillin in combination with other beta-lactam antibiotics.
King JW; Beam TR; Neu HC; Smith LG
Am J Med; 1983 Aug; 75(2A):90-5. PubMed ID: 6311013
[TBL] [Abstract][Full Text] [Related]
4. Amdinocillin in combination with beta-lactam antibiotics for treatment of serious gram-negative infections.
Rotstein C; Farrar WE
Am J Med; 1983 Aug; 75(2A):96-9. PubMed ID: 6311014
[TBL] [Abstract][Full Text] [Related]
5. Morphologic changes produced by amdinocillin alone and in combination with beta-lactam antibiotics: in vitro and in vivo.
Kramer MJ; Mauriz YR; Timmes MD; Robertson TL; Cleeland R
Am J Med; 1983 Aug; 75(2A):30-41. PubMed ID: 6311003
[TBL] [Abstract][Full Text] [Related]
6. Amdinocillin therapy of experimental animal infections.
Gordin FM; Sande MA
Am J Med; 1983 Aug; 75(2A):48-53. PubMed ID: 6311005
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial efficacy of cefazolin and cephradine in neutropenic mice.
Kunst MW; Mattie H; van Furth R
Infection; 1979; 7(1):30-4. PubMed ID: 370021
[TBL] [Abstract][Full Text] [Related]
8. [Sensitivity of Enterobacteriaceae isolated from humans to 6-N,N-1',6'-hexyleneformamidine-penicillanic acid (preparation HX)].
Zaremba M; Zukowska-Nytko K; Grala-Kałuzna A; Kacprzak-Wiatr A; Piotrowski J; Kulikowska A; borowski J
Med Dosw Mikrobiol; 1982; 34(1-2):17-26. PubMed ID: 6292593
[No Abstract] [Full Text] [Related]
9. Randomized trial of cefamandole plus amdinocillin versus cefamandole in serious pediatric infections.
Nelson JD; Kusmiesz H; Shelton S
Am J Med; 1983 Aug; 75(2A):125-9. PubMed ID: 6311000
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of amdinocillin and lack of nephrotoxicity when combined with a second beta-lactam antibiotic for therapy of serious gram-negative bacillary infections.
Sattler FR; Hall S; Hanna CE; Green EA
Am J Med; 1983 Aug; 75(2A):106-12. PubMed ID: 6310997
[TBL] [Abstract][Full Text] [Related]
11. Cefazolin and cephradine: relationship between serum concentrations and tissue contents in mice.
Kunst MW; Mattie H
Infection; 1978; 6(4):166-70. PubMed ID: 357295
[TBL] [Abstract][Full Text] [Related]
12. An evaluation of cephradine oral suspension in the treatment of bacterial infections of infants and children.
Lipman RP; Silverman W
Clin Pediatr (Phila); 1977 Sep; 16(9):835-7. PubMed ID: 330074
[No Abstract] [Full Text] [Related]
13. Parenteral amdinocillin for treatment of complicated urinary tract infections.
Cox CE
Am J Med; 1983 Aug; 75(2A):82-4. PubMed ID: 6311010
[TBL] [Abstract][Full Text] [Related]
14. Combination amdinocillin and cefoxitin therapy of multiply-resistant Serratia marcescens urinary tract infections.
Ward TT; Amon MB; Krause LK
Am J Med; 1983 Aug; 75(2A):85-9. PubMed ID: 6311011
[TBL] [Abstract][Full Text] [Related]
15. Ceftolozane/Tazobactam (Zerbaxa)--a new intravenous antibiotic.
Med Lett Drugs Ther; 2015 Mar; 57(1463):31-3. PubMed ID: 25719997
[No Abstract] [Full Text] [Related]
16. Newer Intravenous Antibiotics in the Intensive Care Unit: Ceftaroline, Ceftolozane-Tazobactam, and Ceftazidime-Avibactam.
Connor KA
AACN Adv Crit Care; 2016 Oct; 27(4):353-357. PubMed ID: 27959289
[No Abstract] [Full Text] [Related]
17. [Recent antibiotics. Range of action, indications, dosage].
Adam D
Anasthesiol Intensivmed Prax; 1975 Oct; 11(1):93-8. PubMed ID: 1243810
[No Abstract] [Full Text] [Related]
18. [Effects of ampicillin and cefazolin combined with mecillinam (author's transl)].
Stille W; Bischof-Léger E; Helm EB
Arzneimittelforschung; 1978; 28(10):1661-4. PubMed ID: 226099
[TBL] [Abstract][Full Text] [Related]
19. In vivo pharmacodynamics of piperacillin/tazobactam: implications for antimicrobial efficacy and resistance suppression with innovator and generic products.
Rodriguez CA; Agudelo M; Zuluaga AF; Vesga O
Int J Antimicrob Agents; 2017 Feb; 49(2):189-197. PubMed ID: 27988068
[TBL] [Abstract][Full Text] [Related]
20. Differences in the changes in resistance patterns to third- and fourth-generation cephalosporins and piperacillin/tazobactam among Klebsiella pneumoniae and Escherichia coli clinical isolates following a restriction policy in a Greek tertiary care hospital.
Petrikkos G; Markogiannakis A; Papaparaskevas J; Daikos GL; Stefanakos G; Zissis NP; Avlamis A
Int J Antimicrob Agents; 2007 Jan; 29(1):34-8. PubMed ID: 17189092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
